A recent internal memo from the Food and Drug Administration has ignited fierce debate in the medical community. Dr. Vinay Prasad, the FDA’s director of vaccine regulation, claimed that at least 10 children died because of COVID-19 vaccination and announced plans to overhaul vaccine approval processes. But the story is far more complex than headlines suggest, and what’s missing from this claim may be just as important as what’s included.
The Memo That Sparked Controversy
In late November 2025, Dr. Prasad sent an internal email to FDA staff stating that a review of reports determined at least 10 out of 96 child deaths reported to the Vaccine Adverse Event Reporting System between 2021 and 2024 were connected to COVID vaccination. He suggested these deaths were likely related to myocarditis, an inflammation of the heart muscle.
The memo announced sweeping changes to vaccine approval standards, including stricter requirements for vaccines given to pregnant women, larger studies for pneumonia vaccines, and reconsideration of multiple vaccines administered simultaneously. Prasad described these deaths as a profound revelation that warranted immediate policy changes.
The Critical Missing Information
Here’s what makes this claim controversial: Dr. Prasad provided no supporting evidence. The memo included no data about the children’s ages, pre-existing medical conditions, the timing of their deaths, which vaccines they received, or the methodology used to determine causation. None of this information has been published in peer-reviewed medical journals or made available for independent expert review.
This absence of detail troubles many scientists. Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, stated that without evidence, Prasad is asking people to trust him on an important issue, and such claims will only cause unnecessary fear. At minimum, experts argue, the complete evidence should be shared so researchers in the field can evaluate whether the data support these conclusions.
Understanding VAERS: A Surveillance System, Not Proof
The claims are based on analysis of the Vaccine Adverse Event Reporting System, a public database where anyone can report health events that occur after vaccination. This is an important distinction: VAERS captures temporal associations, meaning events that happen after vaccination, not necessarily because of vaccination.
Dr. Peter Marks, the FDA’s former top vaccine official who was forced out earlier in 2025, called the agency’s use of VAERS for these claims a misuse of the database. He explained that VAERS serves as an early warning system to identify patterns worth investigating further. The system successfully flagged the rare blood-clotting condition associated with the Johnson & Johnson vaccine, demonstrating its value as a surveillance tool.
However, VAERS reports cannot prove causation on their own. A child could be reported to VAERS after receiving a vaccine but die from an unrelated cause, like a car accident, drowning, or an undiagnosed heart condition. Without a detailed investigation of each case, distinguishing true vaccine-caused deaths from coincidental timing is impossible.
What Does the Scientific Evidence Show?
Multiple large-scale studies examining millions of vaccinated children paint a different picture:
A 2023 analysis in JAMA Pediatrics reviewed 17 studies covering over 10 million children aged five to 11 who received Pfizer or Moderna vaccines. Vaccinated children showed lower risks of infection and hospitalization compared to unvaccinated children.
A 2024 study published in Nature Communications examined 5.1 million children in England and found no increased risk of serious adverse events in young children following COVID vaccination. The study did identify a small increased risk of myocarditis in teenage boys, estimating three additional cases per million after a first dose and five additional cases per million after a second dose of the Pfizer vaccine.
A Canadian study published in The Lancet in late 2024 conducted active surveillance of vaccinated children across eight provinces and found the vaccines to be safe for the pediatric population.
Research has also consistently demonstrated that while myocarditis can occur after COVID vaccination, particularly in young males, the condition is far more common and severe following actual COVID infection than following vaccination.
The Broader Context: A Shift in Vaccine Policy
These claims emerge within a larger transformation of U.S. health policy under Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine critic who founded the anti-vaccine group Children’s Health Defense.
Since taking office, Kennedy has removed all members of the CDC’s vaccine advisory committee, directed changes to CDC websites to include disputed claims linking autism and vaccines, slashed funding for mRNA vaccine development, and restricted eligibility for updated COVID vaccines. The CDC’s Advisory Committee on Immunization Practices is now scheduled to review the childhood vaccination schedule and timing of hepatitis B vaccination.
Dr. Marks, who led Operation Warp Speed during the pandemic and oversaw vaccine approvals for nearly a decade, was forced to resign in March 2025 after refusing what he called demands for confirmation of Kennedy’s views. In his resignation letter, Marks wrote that undermining confidence in well-established vaccines is detrimental to public health and a clear danger to the nation’s health and security.
What About Real Risks?
It’s important to acknowledge that no vaccine is entirely without risk. The mRNA COVID vaccines do carry a known, small risk of myocarditis, particularly in young males. This risk was identified through the very safety monitoring systems now being questioned, and vaccine labels were updated accordingly.
The FDA expanded warnings about myocarditis and pericarditis to males aged 16 to 25 in April 2025. Data showed approximately eight cases per million doses in children and adults under 65. Most cases of vaccine-associated myocarditis have been mild and resolved with supportive care.
However, COVID-19 itself poses significant risks to children. Between 2021 and 2024, COVID caused more pediatric deaths than influenza in children under one year, children aged one to four, and children aged five to 19. More than half of hospitalized children had no underlying health conditions. Multisystem inflammatory syndrome in children, a severe post-COVID complication, affected nearly 10,000 children in the U.S., resulting in 80 deaths.
The Timing and Political Implications
The memo arrived just before a crucial two-day CDC vaccine advisory committee meeting in early December 2025. This committee is conducting a major review of how children are inoculated against diseases, including measles, mumps, rubella, polio, and hepatitis B. Many public health experts worry the committee may significantly alter the childhood vaccination schedule.
The timing has also coincided with an ongoing measles outbreak that has caused hundreds of infections and killed two children. Measles had been effectively eliminated from the United States through vaccination, but declining vaccination rates have allowed it to return.
What Should Parents Do?
This controversy highlights the challenge parents face in navigating conflicting health information. Here are key considerations:
First, recognize that extraordinary claims require extraordinary evidence. Claims of vaccine-caused deaths without supporting data, methodology, or peer review should be approached skeptically, regardless of who makes them.
Second, understand that reputable vaccine safety concerns are identified through rigorous processes and openly published. When legitimate safety signals emerge, such as the myocarditis association with mRNA vaccines or the blood clotting issue with the Johnson & Johnson vaccine, they are thoroughly investigated and publicly documented.
Third, consult with your pediatrician about your child’s specific health situation. Doctors can discuss your child’s individual risk factors, explain the evidence for vaccine safety and effectiveness, and help you make informed decisions.
Fourth, consider the broader context of disease risk. While absolute risks of severe COVID in healthy children are relatively low, they are not zero. Vaccination decisions should weigh both the risks of vaccination and the risks of the disease itself.
The Need for Transparency
Both sides of this debate agree on one thing: transparency matters. If the FDA has evidence that COVID vaccines caused specific deaths in children, that evidence should be published, peer-reviewed, and made available for independent analysis. Medical decisions affecting millions of children deserve nothing less than complete transparency and rigorous scientific scrutiny.
Conversely, if these claims lack sufficient evidence to support such serious allegations, making them public without documentation risks causing unnecessary fear, potentially leading parents to avoid vaccines that could protect their children from serious diseases.
Moving Forward
The debate over COVID vaccine safety for children will likely continue as new data emerges and policies evolve. What remains constant is the need for decisions based on comprehensive evidence, transparent data sharing, and peer-reviewed research.
Parents deserve honest information about both the benefits and risks of medical interventions for their children. Public health depends on trust in institutions that base recommendations on rigorous science rather than political considerations. When that trust erodes, whether through concealing information or making inadequately supported claims, children’s health ultimately suffers.
As this situation develops, staying informed through multiple reputable sources, asking critical questions about evidence quality, and maintaining open conversations with healthcare providers remain the best strategies for protecting children’s health in an era of conflicting information.